BeEAM (bendamustine, etoposide, cytarabine, melphalan) prior to autologous stem cell transplant for chemosensitive relapses in patients with follicular lymphoma: a prospective multicentre phase II study in Lymphoma Study Association centres†.

Hervé GhesquièresCécile DalbanEmmanuelle Nicolas-VirelizierFabrice JardinFabien Le BrasSteven Le GouillOlivier CasasnovasSéraphine VizosoCaroline HernandezSéverine MetzgerDavid PérolGuillaume Cartron

Published in: British journal of haematology (2021)

Keyphrases

phase ii study
stem cells
high dose
open label
acute myeloid leukemia
locally advanced
clinical trial
bone marrow
low dose
squamous cell carcinoma
cross sectional
radiation therapy
randomized controlled trial
double blind
mesenchymal stem cells